Dong B. Ji

302 Military Hospital Of China 100 XiSiHuan Middle Road
Fengtai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Analysis of influencing factors associated with cirrhosis in patients with indeterminate-phase chronic hepatitis B

Analysis of influencing factors associated with cirrhosis in patients with indeterminate-phase chronic hepatitis B

Journal: Zhonghua yi xue za zhi

Published: August 09, 2026

Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction, Authors' Reply.

Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction, Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: July 30, 2026

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: July 27, 2026

The impact of blood ammonia after interventional therapy on the prognosis of patients with unresectable hepatocellular carcinoma.

The impact of blood ammonia after interventional therapy on the prognosis of patients with unresectable hepatocellular carcinoma.

Journal: iLIVER

Published: March 05, 2026

Research progress on hepatitis B surface antigen decline and clearance.

Research progress on hepatitis B surface antigen decline and clearance.

Journal: iLIVER

Published: February 12, 2026

HBsAg Quantification-Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs-Experienced Patients With Chronic Hepatitis B: The HBsAg-HCC Score.

HBsAg Quantification-Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs-Experienced Patients With Chronic Hepatitis B: The HBsAg-HCC Score.

Journal: Alimentary pharmacology & therapeutics

Published: January 28, 2026

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.

Journal: Hepatology international

Published: December 13, 2025

Prognostic Value of Fibrosis-4 in Male Patients with Alcohol-Related Hepatocellular Carcinoma: Implications for Ultrasound-Based Therapeutic Strategies.

Prognostic Value of Fibrosis-4 in Male Patients with Alcohol-Related Hepatocellular Carcinoma: Implications for Ultrasound-Based Therapeutic Strategies.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: November 28, 2025

Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis B.

Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis B.

Journal: Antiviral research

Published: October 08, 2025

Repurposing SGLT2 Inhibitors for Cirrhotic Ascites: From Mechanistic Research to Clinical Exploration.

Repurposing SGLT2 Inhibitors for Cirrhotic Ascites: From Mechanistic Research to Clinical Exploration.

Journal: Journal of clinical and translational hepatology

Published: September 07, 2025

Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites.

Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites.

Journal: World journal of hepatology

Published: June 04, 2025

Assessment of significant hepatic damage in young patients with chronic hepatitis B to initiate the antiviral treatment: The APLB score.

Assessment of significant hepatic damage in young patients with chronic hepatitis B to initiate the antiviral treatment: The APLB score.

Journal: Antiviral research

Published: April 18, 2025

Showing 1-12 of 96

Last Updated: 09/26/2026